title: Cyclosporine, combination immunosuppression, and posttransplant diabetes mellitus.
authors.affiliation: Department of Surgery, University of Minnesota Hospitals and Clinics.
authors.forename: J P
authors.initials: JP
authors.lastname: Boudreaux
authors.forename: L
authors.initials: L
authors.lastname: McHugh
authors.forename: D M
authors.initials: DM
authors.lastname: Canafax
authors.forename: N
authors.initials: N
authors.lastname: Asher
authors.forename: D E
authors.initials: DE
authors.lastname: Sutherland
authors.forename: W
authors.initials: W
authors.lastname: Payne
authors.forename: R L
authors.initials: RL
authors.lastname: Simmons
authors.forename: J S
authors.initials: JS
authors.lastname: Najarian
authors.forename: D S
authors.initials: DS
authors.lastname: Fryd
mesh_terms: D000328:Adult; D000367:Age Factors; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011897:Random Allocation
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone